Net components of basic and diluted earnings per share |
Components of basic and diluted earnings per share and excluded antidilutive potential common shares are as follows: | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | Six Months Ended March 31, | | 2017 | | 2016 | | 2017 | | 2016 | | | | | | | | | | (in thousands, except per share amounts) | Net income from continuing operations attributable to EZCORP (A) | $ | 8,398 |
| | $ | 2,630 |
| | $ | 16,791 |
| | $ | 6,049 |
| Loss from discontinued operations, net of tax (B) | (375 | ) | | (73,442 | ) | | (1,603 | ) | | (84,335 | ) | Net income (loss) attributable to EZCORP (C) | $ | 8,023 |
| | $ | (70,812 | ) | | $ | 15,188 |
| | $ | (78,286 | ) | | | | | | | | | Weighted-average outstanding shares of common stock (D) | 54,291 |
| | 54,843 |
| | 54,224 |
| | 54,869 |
| Dilutive effect of restricted stock | 55 |
| | 93 |
| | 54 |
| | 74 |
| Weighted-average common stock and common stock equivalents (E) | 54,346 |
|
| 54,936 |
|
| 54,278 |
|
| 54,943 |
| | | | | | | | | Basic earnings (loss) per share attributable to EZCORP: | | | | | | | | Continuing operations (A / D) | $ | 0.15 |
| | $ | 0.05 |
| | $ | 0.31 |
| | $ | 0.11 |
| Discontinued operations (B / D) | (0.01 | ) | | (1.34 | ) | | (0.03 | ) | | (1.54 | ) | Basic earnings (loss) per share (C / D) | $ | 0.14 |
| | $ | (1.29 | ) | | $ | 0.28 |
| | $ | (1.43 | ) | | | | | | | | | Diluted earnings (loss) per share attributable to EZCORP: | | | | | | | | Continuing operations (A / E) | $ | 0.15 |
| | $ | 0.05 |
| | $ | 0.31 |
| | $ | 0.11 |
| Discontinued operations (B / E) | (0.01 | ) | | (1.34 | ) | | (0.03 | ) | | (1.53 | ) | Diluted earnings (loss) per share (C / E) | $ | 0.14 |
| | $ | (1.29 | ) | | $ | 0.28 |
| | $ | (1.42 | ) | | | | | | | | | Potential common shares excluded from the calculation of diluted earnings (loss) per share above: | | | | | | | | Restricted stock* | 2,602 |
| | 1,484 |
| | 2,443 |
| | 1,400 |
| Warrants** | 14,317 |
| | 14,317 |
| | 14,317 |
| | 14,317 |
| Total potential common shares excluded | 16,919 |
| | 15,801 |
| | 16,760 |
| | 15,717 |
|
| | * | Includes antidilutive share-based awards as well as performance-based and market conditioned share-based awards that are contingently issuable, but for which the condition for issuance has not been met as of the end of the reporting period. |
| | ** | See Note 5 for discussion of the terms and conditions of these potential common shares. |
|